Gail E. Herman, M.D., Ph.D. is a clinical and biochemical geneticist with research interests in mouse models of cholesterol biosynthesis disorders.
Disorders of sterol synthesis: Beyond Smith–Lemli–Opitz syndrome†
Article first published online: 5 OCT 2012
Copyright © 2012 Wiley Periodicals, Inc.
American Journal of Medical Genetics Part C: Seminars in Medical Genetics
Special Issue: Smith-Lemli-Opitz Syndrome and Related Disorders of Cholesterol Synthesis
Volume 160C, Issue 4, pages 301–321, 15 November 2012
How to Cite
Herman, G. E. and Kratz, L. (2012), Disorders of sterol synthesis: Beyond Smith–Lemli–Opitz syndrome. Am. J. Med. Genet., 160C: 301–321. doi: 10.1002/ajmg.c.31340
How to Cite this Article: Herman GE, Kratz L. 2012. Disorders of sterol synthesis: Beyond Smith–Lemli–Opitz syndrome. Am J Med Genet Part C Semin Med Genet 160C: 301–321.
- Issue published online: 22 OCT 2012
- Article first published online: 5 OCT 2012
This article has been cited by:
- 1Erbliche Stoffwechselkrankheiten – eine Übersicht, medizinische genetik, 2015, 27, 3, 268,
- 2Radiographic features of the skeleton in disorders of post-squalene cholesterol biosynthesis, Pediatric Radiology, 2015, 45, 7, 965, , , , , , , , , , , , ,
- You have free access to this content3
- 4Malformation syndromes associated with disorders of sex development, Nature Reviews Endocrinology, 2014, 10, 8, 476, , , ,
- 5Structure of an integral membrane sterol reductase from Methylomicrobium alcaliphilum, Nature, 2014, 517, 7532, 104, , ,